Associated Papers
Preclinical assessment of combination therapy of EGFR tyrosine kinase inhibitors in a highly heterogeneous tumor model.
Ikeuchi H et al.
Oncogene, 2022
35304574 (PubMed )
Supplement: 41388_2022_2263_MOESM5_ESM.xlsx › Supplementary_Table_4
Mutational Portrait of Lung Adenocarcinoma in Brazilian Patients: Past, Present, and Future of Molecular Profiling in the Clinic.
Freitas HC et al.
Frontiers in Oncology, 2020
32714871 (PubMed )
Supplement: Data_Sheet_1.XLSX › EGFR_Tumor_Tests
EGFR mutational status in a large series of Caucasian European NSCLC patients: data from daily practice.
Gahr S et al.
British Journal of Cancer, 2013
Select a paper to view details